Developer of a drug technology designed to improve the way of storing blood, platelets, and organs. The company’s technology specializes in developing products that extend the lifetime of blood and platelets to nearly double the current standard and plan to extend the lifetime of organs to three to six times the current standard of care, enabling researchers to provide reliable outcomes for transfusion and transplant patients.

Developer of an artificial intelligence automated report generation platform designed to automate repetitive tasks for radiologists. The company’s platform optimizes workflow, integrates seamlessly with existing workflow, automates repetitive and time-consuming tasks, and boosts efficiency, enabling radiologists to improve radiology workflow that maximizes efficiency and accuracy with decreasing turnaround time for patients while also reducing burnout for radiologists and improve patient care.

The company seeks to derestrict birth control pills and make them available over the counter in the United States.

Operator of a personalized health platform intended to empower people to take control of their health. The company offers a personalized health platform that uses AI-powered analytics to track users’ health data and identify potential health risks and provides the knowledge and tools needed to make informed health decisions, enabling customers to live healthy lives by understanding their bodies and taking steps to prevent disease.

Developer of cardiac micro physiological systems designed to offer 3D human cardiac tissue models for advanced analysis. The company’s data science ecosystem uses to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, enabling the health industry to perform safer and cheaper drug development activities.

Provider of preservation services intended for organ transplants. The company’s platform large and interdisciplinary network of advisers and volunteers to advance preservation technologies that could save or improve millions of lives in the coming years, enabling healthcare organizations in catalyzing breakthroughs on the remaining obstacles toward the long-term storage of organs.

On Diagnostics’ mission is to improve patient outcomes by developing non-invasive and clinically effective diagnostic applications that quantitatively exploit the richness of information in CT scans.

Provider of maternity care services intended to offer patients improved clinical outcomes and hassle-free healthcare experience. The company offers a new kind of maternity clinic that allows remote health monitoring, home postpartum visit, parenthood support through the application, and one-to-one doula coaching, providing users extensive care, expert guidance, and support during and after the maternal phase.